ARCA biopharma Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
ARCA biopharma stock downgraded from Strong Buy Candidate to Buy Candidate after Wednesday trading session.
(Updated on Apr 17, 2024)
The ARCA biopharma stock price fell by -1.83% on the last day (Wednesday, 17th Apr 2024) from $3.27 to $3.21. During the last trading day the stock fluctuated 5.75% from a day low at $3.13 to a day high of $3.31. The price has been going up and down for this period, and there has been a -1.23% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -200 thousand shares and in total, 95 thousand shares were bought and sold for approximately $305.07 thousand.
The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $3.29 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 72.23% during the next 3 months and, with a 90% probability hold a price between $3.37 and $5.67 at the end of this 3-month period.
ABIO Signals & Forecast
The ARCA biopharma stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.20 and $2.16. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 16, 2024, and so far it has fallen -1.83%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The stock had a Golden Star Signal on Friday, September 15, 2023 in the long-term chart.
Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Golden Star 12 Months
The stock had a Golden Star Signal on Friday, September 15, 2023 in the long-term chart.Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Support, Risk & Stop-loss for ARCA biopharma stock
ARCA biopharma finds support from accumulated volume at $3.09 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.180 between high and low, or 5.75%. For the last week the stock has had daily average volatility of 5.16%.
The ARCA biopharma stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.
Our recommended stop-loss: $3.08 (-4.08%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 81 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (ABIO) For The Upcoming Trading Day Of Thursday 18th
For the upcoming trading day on Thursday, 18th we expect ARCA biopharma to open at $3.22, and during the day (based on 14 day Average True Range), to move between $3.01 and $3.41, which gives a possible trading interval of +/-$0.200 (+/-6.23%) up or down from last closing price. If ARCA biopharma takes out the full calculated possible swing range there will be an estimated 12.46% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $3.23 (0.62%) than the support at $3.09 (3.74%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
ARCA biopharma will release earnings BMO on Monday, April 22, 2024. We will update the financials statements for ARCA biopharma, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 5.24% in the first trading day after earnings release.
Is ARCA biopharma stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for ARCA biopharma stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.
Current score: 3.188 Buy Candidate Downgraded
Predicted Opening Price for ARCA biopharma of Thursday, April 18, 2024
| Fair opening price April 18, 2024 | Current price |
|---|---|
| $3.22 ( 0.208%) | $3.21 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ABIO
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.40 | 5.82 % | |
| R2 | 3.33 | 3.67 % | ||
| R1 | 3.29 | 2.35 % | ||
| Current price: | 3.21 | |||
| Support | S1 | 3.15 | -1.93 % | |
| S2 | 3.11 | -3.26 % | ||
| S3 | 3.04 | -5.40 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.27 | 1.87 % | |
| R2 | 3.25 | 1.25 % | ||
| R1 | 3.23 | 0.623 % | ||
| Current price | 3.21 | |||
| Support | S1 | 3.09 | -3.74% | |
| S2 | 3.08 | -4.05% | ||
| S3 | 3.00 | -6.54% |
FAQ
Click here for our free guide on how to buy ARCA biopharma Stock.
